FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

784175006: Human epidermal growth factor receptor 2 inhibitor (disposition)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3761510015 Human epidermal growth factor receptor 2 inhibitor en Synonym Active Entire term case insensitive SNOMED CT core module
3761511016 HER2 (Human epidermal growth factor receptor 2) inhibitor en Synonym Active Entire term case sensitive SNOMED CT core module
3761512011 Human epidermal growth factor receptor 2 inhibitor (disposition) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Human epidermal growth factor receptor 2 inhibitor Is a Protein-tyrosine kinase inhibitor false Inferred relationship Existential restriction modifier
Human epidermal growth factor receptor 2 inhibitor Is a Epidermal growth factor receptor inhibitor true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Trastuzumab Has disposition True Human epidermal growth factor receptor 2 inhibitor Inferred relationship Existential restriction modifier
Pertuzumab Has disposition True Human epidermal growth factor receptor 2 inhibitor Inferred relationship Existential restriction modifier
Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) Has disposition True Human epidermal growth factor receptor 2 inhibitor Inferred relationship Existential restriction modifier
Trastuzumab emtansine Has disposition True Human epidermal growth factor receptor 2 inhibitor Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan Has disposition True Human epidermal growth factor receptor 2 inhibitor Inferred relationship Existential restriction modifier
Margetuximab Has disposition True Human epidermal growth factor receptor 2 inhibitor Inferred relationship Existential restriction modifier
Lapatinib Has disposition True Human epidermal growth factor receptor 2 inhibitor Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start